Abstract:Tumors pose a significant threat to human health, and their occurrence and fatality rates are on the rise each year. Accurate tumor diagnosis is crucial in preventing untimely treatment and late-stage metastasis, thereby reducing mortality. To address this, we have developed a novel type of hybrid nanogels called γ-Fe2O3@PNIPAM/PAm/CTS, which contain iron oxide nanoparticles and poly(N-isopropyl acrylamide)/poly(acrylamide)/chitosan. The rational for this study relies on the concept that thermosensitive PNIPAM has the ability to contract when exposed to the elevated temperature conditions found within tumors. This contraction leads to a dense clustering of the high-loading γ-Fe2O3 nanoparticles within the nanogel, thus greatly enhancing the capabilities of MRI imaging. Additionally, the amino groups in chitosan on the particle surface can be converted into ammonium salts under mildly acidic conditions, allowing for an increase in the charge of the nanogel specifically at the slightly acidic tumor site. Consequently, it promotes the phagocytosis of tumor cells and effectively enhances the accumulation and retention of nanogels at the tumor site. The synthesis of the hybrid nanogels involves a surfactant-free emulsion copolymerization process, where vinyl-modified γ-Fe2O3 superparamagnetic nanoparticles are copolymerized with the monomers in the presence of chitosan. We have optimized various reaction parameters to achieve a high loading content of the superparamagnetic nanoparticles, reaching up to 60%. The achieved r2 value of 517.74 mM-1S-1 significantly surpasses that of the clinical imaging contrast agent Resovist (approximately 151 mM-1S-1). To assess the performance of these magnetic nanogels, we conducted experiments using Cal27 oral tumors and 4T1 breast tumors in animal models. The nanogels exhibited temperature- and pH-sensitivity, enabling magnetic targeting and enhancing diagnosis through MRI imaging. The results demonstrated the potential of these hybrid nanogels as contrast agents for magnetic targeting in biomedical applications.

Exogenous Amino Acid‐Loaded Nanovehicles: Stepping Across Endogenous Magnetic Resonance Spectroscopy

Ultra-Small and Metabolizable Near-Infrared Au/Gd Nanoclusters for Targeted FL/MRI Imaging and Cancer Theranostics

Gadolinium‐based Contrast Agents for Magnetic Resonance Cancer Imaging

Iron oxide nanoclusters formed by acid-induced in situ calcium ion cross-linking for targeted magnetic resonance imaging of glioblastoma

Highly Sensitive Diagnosis of Extracellular Calcium Ions Associated Brain Diseases using Ca2+‐Dependent T2‐T1 Switchable Magnetic Nanosensors

Crosslinked Albumin-Manganese Nanoaggregates with Sensitized T1 Relaxivity and Indocyanine Green Loading for Multimodal Imaging and Cancer Phototherapy

Enhancing MRI imaging through high loading of superparamagnetic nanogels with high sensitivity to the tumor environment

Biocompatibility and proteomic profiling of DMSA-coated iron nanocubes in a human glioblastoma cell line

Redox-triggered Aggregation of ESIONPs with Switchable T1 to T2 Contrast Effect for T2-weighted Magnetic Resonance Imaging.

Dual-Modality Imaging Probes with High Magnetic Relaxivity and Near-Infrared Fluorescence Based Highly Aminated Mesoporous Silica Nanoparticles

pH‐responsive albumin‐mimetic synthetic nanoprobes for magnetic resonance/fluorescence imaging of thyroid cancer

Amorphous Albumin Gadolinium-Based Nanoparticles for Ultrahigh-Resolution Magnetic Resonance Angiography

Advances in magnetic nanoparticle-based magnetic resonance imaging contrast agents

Synergistic Regulation of Longitudinal and Transverse Relaxivity of Extremely Small Iron Oxide Nanoparticles (esionps) Using Ph-Responsive Nanoassemblies.

In Vivo Magnetic Resonance Spectroscopy by J-Locked Chemical Shift Encoding for Determination of Neurochemical Concentration and Transverse Relaxation Time

Gadolinium-based Nanoscale MRI Contrast Agents for Tumor Imaging

Ligand‐Mediated Magnetism‐Conversion Nanoprobes for Activatable Ultra‐High Field Magnetic Resonance Imaging

Engineering nanoprobes for magnetic resonance imaging of brain diseases

Iron oxide/manganese oxide co-loaded hybrid nanogels as pH-responsive magnetic resonance contrast agents.

Single‐Atom Gd Nanoprobes for Self‐Confirmative MRI with Robust Stability

Biodegradable Nanoglobular Magnetic Resonance Imaging Contrast Agent Constructed with Host-Guest Self-Assembly for Tumor-Targeted Imaging.